Ragnar Crossover Fund is the London-based investment arm of Ragnar Capital Partners LLP, focused on growth capital and financing for high-growth companies. It backs or finances companies through private placements, Series A and later rounds, pre-IPO and IPO financings, convertible debt, traditional debt and mezzanine finance. The firm has UK, US and global investment reach, with sector exposure across finance, fintech, biotechnology, healthtech, medical devices, life sciences and TMT.